Literature DB >> 16039691

Contribution of retinal neurons to d-wave of primate photopic electroretinograms.

Shinji Ueno1, Mineo Kondo, Makiko Ueno, Kentaro Miyata, Hiroko Terasaki, Yozo Miyake.   

Abstract

The purpose of this study was to determine the contribution of different types of retinal neurons to the d-wave of the primate electroretinogram using pharmacological agents. NMDA + TTX was used to suppress inner retinal activity, and APB and PDA to block the activity of the ON- and OFF-pathways, respectively. Results indicated that the inner retinal neurons had a small but certain contribution to the d-wave. The initial rapid phase of the d-wave originates from the activity of the cone OFF-pathway nearly exclusively, and the later slow phase is shaped by the cone photoreceptors. The cone ON-pathway acts in a direction opposite to that of the other components.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039691     DOI: 10.1016/j.visres.2005.05.026

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  25 in total

1.  Electroretinographic evaluation of the retinal S-cone system.

Authors:  Maja Sustar; Marko Hawlina; Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2011-11-27       Impact factor: 2.379

2.  On- and off-response ERGs elicited by sawtooth stimuli in normal subjects and glaucoma patients.

Authors:  Gobinda Pangeni; Robert Lämmer; Ralf P Tornow; Folkert K Horn; Jan Kremers
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

3.  Flow of energy in the outer retina in darkness and in light.

Authors:  Jonathan D Linton; Lars C Holzhausen; Norbert Babai; Hongman Song; Kiyoharu J Miyagishima; George W Stearns; Ken Lindsay; Junhua Wei; Andrei O Chertov; Theo A Peters; Romeo Caffe; Helma Pluk; Mathias W Seeliger; Naoyuki Tanimoto; Kimberly Fong; Laura Bolton; Denise L T Kuok; Ian R Sweet; Theodore M Bartoletti; Roxana A Radu; Gabriel H Travis; Willam N Zagotta; Ellen Townes-Anderson; Ed Parker; Catharina E E M Van der Zee; Alapakkam P Sampath; Maxim Sokolov; Wallace B Thoreson; James B Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

4.  ON- and OFF-response of the photopic electroretinogram in relation to stimulus characteristics.

Authors:  Maja Sustar; Marko Hawlina; Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2006-08-12       Impact factor: 2.379

5.  Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.

Authors:  M Sustar; D Perovšek; I Cima; B Stirn-Kranjc; M Hawlina; J Brecelj
Journal:  Doc Ophthalmol       Date:  2015-02-07       Impact factor: 2.379

Review 6.  Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Authors:  Ido Perlman
Journal:  Doc Ophthalmol       Date:  2008-11-09       Impact factor: 2.379

7.  Spatial distributions of on- and off-responses determined with the multifocal ERG.

Authors:  Anderson R Rodrigues; Manoel da Silva Filho; Luiz Carlos L Silveira; Jan Kremers
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

8.  GABAa and GABAc receptor-mediated modulation of responses to color stimuli: electroretinographic study in the turtle Emys orbicularis.

Authors:  Petia Kupenova; Lily Vitanova; Elka Popova
Journal:  J Neural Transm (Vienna)       Date:  2010-03-06       Impact factor: 3.575

9.  ISCEV extended protocol for the stimulus-response series for light-adapted full-field ERG.

Authors:  Daphne L McCulloch; Mineo Kondo; Ruth Hamilton; Pierre Lachapelle; André M V Messias; Anthony G Robson; Shinji Ueno
Journal:  Doc Ophthalmol       Date:  2019-03-30       Impact factor: 2.379

10.  Photopic ON- and OFF-responses in complete type of congenital stationary night blindness in relation to stimulus intensity.

Authors:  Maja Sustar; Branka Stirn-Kranjc; Marko Hawlina; Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2007-11-18       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.